Skip to main content
Log in

Higher Lipophilic Index Indicates Higher Risk of Coronary Heart Disease in Postmenopausal Women

  • Original Article
  • Published:
Lipids

Abstract

Fatty acids (FAs) are essential components of cell membranes and play an integral role in membrane fluidity. The lipophilic index [LI, defined as the sum of the products between FA levels and melting points (°C), divided by the total amount of FA: \({\text{LI}} = \frac{{\mathop \sum \nolimits_{k} [{\text{fatty acid}} \times {\text{melting point}}]}}{{\mathop \sum \nolimits_{k} {\text{fatty acid}} }}\)] is thought to reflect membrane and lipoprotein fluidity and may be associated with the risk of coronary heart disease (CHD). Therefore, we examined the associations of dietary and plasma phospholipid (PL) LI with CHD risk among postmenopausal women. We determined dietary LI for the cohort with completed baseline food frequency questionnaires and free of prevalent cardiovascular diseases in the Women’s Health Initiative (WHI) observational study (N = 85,563). We additionally determined plasma PL LI in a matched case-control study (N = 2428) nested within the WHI observational cohort study. Cox proportional hazard regression and multivariable conditional logistic regression were used to calculate HRs/ORs for CHD risk between quartiles of LI after adjusting for potential sources of confounding and selection bias. Higher dietary LI in the cohort study and plasma PL LI in the case-control study were significantly associated with increased risk of CHD: HR = 1.18 (95% CI 1.07–1.31, P for trend <0.01) and OR = 1.76 (95% CI 1.33–2.33, P for trend <0.01) comparing extreme quartiles and adjusting for potential confounders. These associations still persisted after adjusting for the polyunsaturated to saturated fat ratio. Our study indicated that higher LI based on either dietary or plasma measurements, representing higher FA lipophilicity, was associated with elevated risk of CHD among postmenopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

CHD:

Coronary heart disease

CI:

Confidence interval

CVD:

Cardiovascular disease

FA:

Fatty acid

HR:

Hazard ratio

IQR:

Interquartile range

LI:

Lipophilic index

MET:

Metabolic equivalent of task

MUFA:

Monounsaturated fatty acid

OR:

Odds ratio

PL:

Phospholipid

PUFA:

Polyunsaturated fatty acid

RR:

Risk ratio

SD:

Standard deviation

SFA:

Saturated fatty acid

TFA:

Trans fatty acid

WHI:

Women’s Health Initiative

References

  1. Mozaffarian D et al (2015) Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131(4):e29–e322

    Article  PubMed  Google Scholar 

  2. The Antiretroviral Therapy Cohort Collaboration (2013) Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe, and the United States. Clin Infect Dis 56(12):1800–1809 (Epub 2013 March 1)

    Article  Google Scholar 

  3. Cooper RA (1977) Abnormalities of cell-membrane fluidity in the pathogenesis of disease. N Engl J Med 297(7):371–377

    Article  CAS  PubMed  Google Scholar 

  4. Hodson L, Skeaff CM, Fielding BA (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47(5):348–380

    Article  CAS  PubMed  Google Scholar 

  5. Ding EL et al (2008) Lipophilic index of fatty acid fluidity in erythrocyte and plasma and risk of coronary heart disease. Circulation 118(S_1089):10

    Google Scholar 

  6. Wu H et al (2013) A novel fatty acid lipophilic index and risk of CHD in US men: the health professionals follow-up study. Br J Nutr 110(3):466–474

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Toledo E et al (2013) A novel fatty acid profile index—the lipophilic index—and risk of myocardial infarction. Am J Epidemiol 178(3):392–400

    Article  PubMed  PubMed Central  Google Scholar 

  8. The Women’s Health Initiative Study Group (1998) Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 19(1):61–109

    Article  Google Scholar 

  9. Hays J et al (2003) The Women’s Health Initiative recruitment methods and results. Ann Epidemiol 13(9 Suppl):S18–S77

    Article  PubMed  Google Scholar 

  10. Curb JD et al (2003) Outcomes ascertainment and adjudication methods in the Women’s Health Initiative. Ann Epidemiol 13(9 Suppl):S122–S128

    Article  PubMed  Google Scholar 

  11. Matthan NR et al. (2014) Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: a nested case-control study within the Women’s Health Initiative Observational Study. J Am Heart Assoc 3(4). doi:10.1161/JAHA.113.000764

  12. Lichtenstein AH et al (2006) Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am J Clin Nutr 84(3):497–504

    CAS  PubMed  Google Scholar 

  13. Hu FB et al (1999) Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149(6):531–540

    Article  CAS  PubMed  Google Scholar 

  14. Bertoia ML et al (2013) Long-term alcohol and caffeine intake and risk of sudden cardiac death in women. Am J Clin Nutr 97(6):1356–1363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Resche-Rigon M, White IR (2016) Multiple imputation by chained equations for systematically and sporadically missing multilevel data. Stat Methods Med Res. doi:10.1177/0962280216666564

    Google Scholar 

  16. Office of National AIDS Policy. National HIV/AIDS Strategy for the United States: Update of 2014 Federal Actions to Achieve National Goals and Improve Outcomes Along the HIV Care Continuum. 2014

  17. McTiernan A et al (2003) Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women’s Health Initiative Cohort Study. JAMA 290(10):1331–1336

    Article  CAS  PubMed  Google Scholar 

  18. Hernán MA, Hernandez-Diaz S, Robins JM (2004) A structural approach to selection bias. Epidemiology 15(5):615–625

    Article  PubMed  Google Scholar 

  19. Howe CJ et al (2016) Selection bias due to loss to follow up in cohort studies. Epidemiology 27(1):91–97

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hernan MA et al (2002) Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 155(2):176–184

    Article  PubMed  Google Scholar 

  21. Ding EL et al (2015) Dietary lipophilic load and dietary lipophilic index with risk of coronary heart disease in middle-aged women: beyond conventional fat classifications. Circulation 131(Suppl 1):A19

    Google Scholar 

  22. van Meer G, Voelker DR, Feigenson GW (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9(2):112–124

    Article  PubMed  PubMed Central  Google Scholar 

  23. Zicha J, Kunes J, Devynck MA (1999) Abnormalities of membrane function and lipid metabolism in hypertension: a review. Am J Hypertens 12(3):315–331

    Article  CAS  PubMed  Google Scholar 

  24. Singh U, Jialal I (2006) Oxidative stress and atherosclerosis. Pathophysiology 13(3):129–142

    Article  CAS  PubMed  Google Scholar 

  25. Dumas D et al (1999) Membrane fluidity and oxygen diffusion in cholesterol-enriched endothelial cells. Clin Hemorheol Microcirc 21(3–4):255–261

    CAS  PubMed  Google Scholar 

  26. Gojova A, Barakat AI (2005) Vascular endothelial wound closure under shear stress: role of membrane fluidity and flow-sensitive ion channels. J Appl Physiol (1985) 98(6):2355–2362

    Article  Google Scholar 

  27. Tsuda K (2015) Association of resistin with impaired membrane fluidity of red blood cells in hypertensive and normotensive men: an electron paramagnetic resonance study. Heart Vessels 31(10):1724–1730. doi:10.1007/s00380-015-0755-0

    Article  PubMed  Google Scholar 

  28. Sola R et al (1990) Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta 1043(1):43–51

    Article  CAS  PubMed  Google Scholar 

  29. Soutar A (1978) Does dietary fat influence plasma lipoprotein structure? Nature 273(5657):11–12

    Article  CAS  PubMed  Google Scholar 

  30. Parks JS et al (2000) Phosphatidylcholine fluidity and structure affect lecithin:cholesterol acyltransferase activity. J Lipid Res 41(4):546–553

    CAS  PubMed  Google Scholar 

  31. Berrougui H et al (2007) Age-related impairment of HDL-mediated cholesterol efflux. J Lipid Res 48(2):328–336

    Article  CAS  PubMed  Google Scholar 

  32. Harper CR, Jacobson TA (2001) The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 161(18):2185–2192

    Article  CAS  PubMed  Google Scholar 

  33. Demaison L, Moreau D (2002) Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol Life Sci 59(3):463–477

    Article  CAS  PubMed  Google Scholar 

  34. Mozaffarian D, Wu JH (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58(20):2047–2067

    Article  CAS  PubMed  Google Scholar 

  35. Clarke SD (2004) The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol 15(1):13–18

    Article  CAS  PubMed  Google Scholar 

  36. Manco M, Calvani M, Mingrone G (2004) Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab 6(6):402–413

    Article  CAS  PubMed  Google Scholar 

  37. Emken EA et al (1979) Incorporation of deuterium-labeled cis- and trans-9-octadecenoic acids in humans: plasma, erythrocyte, and platelet phospholipids. Lipids 14(6):547–554

    Article  CAS  PubMed  Google Scholar 

  38. Mozaffarian D et al (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354(15):1601–1613

    Article  CAS  PubMed  Google Scholar 

  39. Sun Q et al (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115(14):1858–1865

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

WHI investigators Program Office: (National Heart, Lung, and Blood Institute, Bethesda, Maryland) Elizabeth Nabel, Jacques Rossouw, Shari Ludlam, Joan McGowan, Leslie Ford, and Nancy Geller. Clinical Coordinating Center: (Fred Hutchinson Cancer Research Center, Seattle, WA). Ross Prentice, Garnet Anderson, Andrea LaCroix, Charles L. Kooperberg, Ruth E. Patterson, Anne McTiernan; (Medical Research Labs, Highland Heights, KY) Evan Stein; (University of California at San Francisco, San Francisco, CA) Steven Cummings. Clinical Centers: (Albert Einstein College of Medicine, Bronx, NY) Sylvia Wassertheil-Smoller; (Baylor College of Medicine, Houston, TX) Aleksandar Rajkovic; (Brigham and Women’s Hospital, Harvard Medical School, Boston, MA) JoAnn E. Manson; (Brown University, Providence, RI) Charles B. Eaton; (Emory University, Atlanta, GA) Lawrence Phillips; (Fred Hutchinson Cancer Research Center, Seattle, WA) Shirley Beresford; (George Washington University Medical Center, Washington, DC) Lisa Martin; (Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA) Rowan Chlebowski; (Kaiser Permanente Center for Health Research, Portland, OR) Yvonne Michael; (Kaiser Permanente Division of Research, Oakland, CA) Bette Caan; (Medical College of Wisconsin, Milwaukee, WI) Jane Morley Kotchen; (MedStar Research Institute/Howard University, Washington, DC) Barbara V. Howard; (Northwestern University, Chicago/Evanston, IL) Linda Van Horn; (Rush Medical Center, Chicago, IL) Henry Black; (Stanford Prevention Research Center, Stanford, CA) Marcia L. Stefanick; (State University of New York at Stony Brook, Stony Brook, NY) Dorothy Lane; (The Ohio State University, Columbus, OH) Rebecca Jackson; (University of Alabama at Birmingham, Birmingham, AL) Cora E. Lewis; (University of Arizona, Tucson/Phoenix, AZ) Cynthia A Thomson; (University at Buffalo, Buffalo, NY) Jean Wactawski-Wende; (University of California at Davis, Sacramento, CA) John Robbins; (University of California at Irvine, CA) F. Allan Hubbell; (University of California at Los Angeles, Los Angeles, CA) Lauren Nathan; (University of California at San Diego, LaJolla/Chula Vista, CA) Robert D. Langer; (University of Cincinnati, Cincinnati, OH) Margery Gass; (University of Florida, Gainesville/Jacksonville, FL) Marian Limacher; (University of Hawaii, Honolulu, HI) J. David Curb; (University of Iowa, Iowa City/Davenport, IA) Robert Wallace; (University of Massachusetts/Fallon Clinic, Worcester, MA) Judith Ockene; (University of Medicine and Dentistry of New Jersey, Newark, NJ) Norman Lasser; (University of Miami, Miami, FL) Mary Jo O’Sullivan; (University of Minnesota, Minneapolis, MN) Karen Margolis; (University of Nevada, Reno, NV) Robert Brunner; (University of North Carolina, Chapel Hill, NC) Gerardo Heiss; (University of Pittsburgh, Pittsburgh, PA) Lewis Kuller; (University of Tennessee Health Science Center, Memphis, TN) Karen C. Johnson; (University of Texas Health Science Center, San Antonio, TX) Robert Brzyski; (University of Wisconsin, Madison, WI) Gloria E. Sarto; (Wake Forest University School of Medicine, Winston-Salem, NC) Mara Vitolins; (Wayne State University School of Medicine/Hutzel Hospital, Detroit, MI) Michael Simon. Women’s Health Initiative Memory Study: (Wake Forest University School of Medicine, Winston-Salem, NC) Sally Shumaker.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles B. Eaton.

Ethics declarations

Conflict of interest

There is no potential conflict of interest.

Appendices

Appendix 1. Causal diagrams hypothesized for the two study designs

See Fig. 2.

Fig. 2
figure 2

I Dietary LI in cohort study. II Plasma PL LI in matched case-control study. C1 includes age, region, race/ethnicity, education, income, BMI, physical activity, smoking, family history of myocardial infarction/diabetes/stroke, medication use, postmenopausal hormone use, self-reported baseline hypertension/diabetes/cancer/hypercholesterolemia/hysterectomy status, dietary alcohol, percent calories from protein and carbohydrates, and total energy intake. C2 includes age, region, race/ethnicity, education, income, self-reported baseline hypertension/diabetes/cancer/hypercholesterolemia, and hysterectomy status. C3 includes age, race/ethnicity, hysterectomy status, BMI, physical activity, smoking, family history of myocardial infarction/diabetes/stroke, medication use, postmenopausal hormone use, self-reported baseline hypertension/diabetes/cancer/hypercholesterolemia, dietary alcohol, percent calories from protein and carbohydrates, and total energy intake. A box around a node represents conditioning on that node

Appendix 2

See Table 4.

Table 4 Melting points and median (IQR) levels for individual fatty acids and Spearman’s correlation coefficients (r) for correlation between individual fatty acids and the lipophilic index measured in diets from the cohort study (1994–2014) and in plasma PL from the case-control study (1994–2005) of the Women’s Health Initiative

Appendix 3

See Table 5.

Table 5 Hazard ratios (95% confidence interval) for CHD according to quartiles of dietary lipophilic index/load among participants without missing covariates in the cohort study (1994–2014, N = 60,079) of the Women’s Health Initiative

Appendix 4

See Table 6.

Table 6 Hazard ratios (95% confidence interval) for CHD according to quartiles of dietary lipids in the cohort study (1994–2014, N = 85,563) of the Women’s Health Initiative

Appendix 5

See Table 7.

Table 7 Hazard ratios (95% confidence interval) for CHD according to quartiles of dietary lipophilic index and lipids among participants with blood lipids in the cohort study (1994–2014, N = 6,188) of the Women’s Health Initiative

Appendix 6

See Table 8.

Table 8 Hazard ratios (95% confidence interval) for CHD according to quartiles of dietary lipophilic index/load calculated using different methods among participants in the cohort study (1994–2014, N = 85,563) of the Women’s Health Initiative

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Q., Lichtenstein, A.H., Matthan, N.R. et al. Higher Lipophilic Index Indicates Higher Risk of Coronary Heart Disease in Postmenopausal Women. Lipids 52, 687–702 (2017). https://doi.org/10.1007/s11745-017-4276-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11745-017-4276-8

Keywords

Navigation